Standout Papers

Empagliflozin, Cardiovascular Outcomes, and Mortality i... 2007 2026 2013 2019 7.8k
  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (2015)
    Bernard Zinman, Christoph Wanner et al. New England Journal of Medicine
  2. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial (2007)
    Bengt I. Eriksson, Ola E. Dahl et al. The Lancet
  3. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial (2007)
    Bengt I. Eriksson, O.E. Dahl et al. Journal of Thrombosis and Haemostasis
  4. How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial (2017)
    Silvio E. Inzucchi, Bernard Zinman et al. Diabetes Care
  5. Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery (2008)
    Jeffrey S. Ginsberg, Bruce L. Davidson et al. The Journal of Arthroplasty

Immediate Impact

2 from Science/Nature 111 standout
Sub-graph 1 of 13

Citing Papers

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
2022 Standout
1 intermediate paper

Works of Stefan Hantel being referenced

How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial
2024
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Stefan Hantel 9082 4555 3893 4747 62 13.3k
Marc P. Bonaca 6800 5664 3047 6514 273 14.6k
Benjamin M. Scirica 5590 6415 2442 12228 268 18.5k
Christian T. Ruff 4155 2499 1875 9031 169 13.9k
Julia Kuder 4736 3409 1865 3030 59 8.4k
Rafael Díaz 3763 2930 1423 12341 128 17.8k
David Fitchett 12416 6610 5125 5737 198 18.0k
Jean MacFadyen 3194 7907 1915 3965 56 14.9k
Erich Bluhmki 7567 3884 4095 3689 80 23.6k
Stephen D. Wiviott 10804 15064 3804 21684 200 33.8k
R. Scott Wright 1938 6304 1556 8491 120 14.4k

All Works

Loading papers...

Rankless by CCL
2026